Following B16F10 tumor cell injection, a markedly higher number of metastatic cells were observed in TRPM2−/− NK cell-treated mice than in TRPM2+/+ NK cell-treated mice (Fig. 1g). This evidence concerns the gene TRPM2 and neoplasm.